StockData
Propanc Biopharma, Inc. logo

Propanc Biopharma, Inc. (PPCB) stock

PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$0.32−0.03 (-7.31%)

Close on Oct 19, 2026Market cap $1.70MP/E –Yield –

Propanc Biopharma free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Propanc Biopharma's free cash flow for the twelve months ending Jun 30, 2026 was -$5.69M. For fiscal 2026 it was -$5.69M. The highest annual figure on record is -$226.44K in fiscal 2014.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$5.69M–
FY2019Jun 30, 2019-$2.06M–
FY2016Jun 30, 2016-$4.51M–
FY2015Jun 30, 2015-$1.43M–
FY2014Jun 30, 2014-$226.44K–
FY2011Jun 30, 2011-$1.40M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026-$1.60M–
Q3 FY2026CQ1 2026Mar 31, 2026-$1.14M–
Q2 FY2026CQ4 2025Dec 31, 2025-$1.00M–
Q1 FY2026CQ3 2025Sep 30, 2025-$1.94M–
Q4 FY2019CQ2 2019Jun 30, 2019-$266.23K–
Q3 FY2019CQ1 2019Mar 31, 2019-$738.23K–
Q2 FY2017CQ4 2016Dec 31, 2016-$321.03K–

More Propanc Biopharma figures

See a number that looks wrong?